ABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Antipsychotic Agents/administration & dosage , Antipsychotic Agents/adverse effects , Antipsychotic Agents/therapeutic use , Tobacco Smoke Pollution/adverse effects , Smoking/adverse effects , Affective Disorders, Psychotic/chemically induced , Affective Disorders, Psychotic/drug therapy , Psychotic Disorders/complications , Psychotic Disorders/diagnosis , Psychotic Disorders/drug therapy , Psychoses, Substance-Induced/complications , Psychoses, Substance-Induced/diagnosis , Psychoses, Substance-Induced/therapyABSTRACT
Introducción. Importancia de los efectos cardiovasculares, fundamentalmente las arritmias ventriculares, producidos por los antipsicóticos. Caso clínico. Paciente de 28 años con obesidad mórbida, por la que fue intervenido obteniendo buenos resultados, sufre una taquicardia ventricular no sostenida polimórfica mientras realizaba tratamiento farmacológico con aripiprazol y fluoxetina. Conclusiones. Valorar la influencia de diversos factores en la producción de arritmias ventriculares, destacando fundamentalmente las interacciones de los antipsicóticos y la pérdida de peso (AU)
Introduction. The Importance of the cardiovascular effects, fundamentally the ventricular arrhythmias, produced by the antipsychotic ones, is discussed. Clinical case. 28 year old patient with morbid obesity, operated by bariatric surgery, with good result, suffers a ventricular no supported polymorphic tachycardia while he was heightening treatment with aripiprazole and fluoxetine. Conclusions. To value the influence of diverse factors for the production of ventricular arrhythmias emphasizing fundamentally the interactions of aripiprazole and the loss of weight (AU)
Subject(s)
Humans , Male , Adult , Weight Loss , Antidepressive Agents , Antipsychotic Agents , Arrhythmias, Cardiac/chemically induced , Obesity, Morbid/surgery , Drug Interactions , Schizoid Personality Disorder/drug therapyABSTRACT
INTRODUCTION: The Importance of the cardiovascular effects, fundamentally the ventricular arrhythmias, produced by the antipsychotic ones, is discussed. CLINICAL CASE: 28 year old patient with morbid obesity, operated by bariatric surgery, with good result, suffers a ventricular no supported polymorphic tachycardia while he was heightening treatment with aripiprazole and fluoxetine. CONCLUSIONS: To value the influence of diverse factors for the production of ventricular arrhythmias emphasizing fundamentally the interactions of aripiprazole and the loss of weight.
